Papillomavirus vaccine compositions
    2.
    发明授权
    Papillomavirus vaccine compositions 有权
    乳头瘤病毒疫苗组合物

    公开(公告)号:US07709010B2

    公开(公告)日:2010-05-04

    申请号:US12074783

    申请日:2008-03-06

    IPC分类号: A61K45/00

    摘要: The present invention relates to pharmaceutical compositions comprising virus-like particles (VLPs) of HPV, said VLPs adsorbed to an aluminum adjuvant, and an ISCOM-type adjuvant comprising a saponin, cholesterol, and a phospholipid. In preferred embodiments, the aluminum adjuvant comprises amorphous aluminum hydroxyphosphate sulfate. Another aspect of the invention provides multi-dose HPV vaccine formulations comprising HPV VLPs and an antimicrobial preservative selected from the group consisting of: m-cresol, phenol and benzyl alcohol. Also provided are methods of using the disclosed pharmaceutical compositions and formulations to induce an immune response against HPV in a human patient and to prevent HPV infection.

    摘要翻译: 本发明涉及包含HPV病毒样颗粒(VLP),所述VLP吸附于铝佐剂的IS​​MA型佐剂和包含皂角苷,胆固醇和磷脂的ISCOM型佐剂的药物组合物。 在优选的实施方案中,铝佐剂包括无定形的羟基磷酸氢铝硫酸盐。 本发明的另一方面提供了包含HPV VLP和选自间甲酚,苯酚和苄醇的抗微生物防腐剂的多剂量HPV疫苗制剂。 还提供了使用所公开的药物组合物和制剂在人类患者中诱导针对HPV的免疫应答并防止HPV感染的方法。

    PAPILLOMAVIRUS VACCINE COMPOSITIONS
    4.
    发明申请
    PAPILLOMAVIRUS VACCINE COMPOSITIONS 审中-公开
    肉毒杆菌组合物

    公开(公告)号:US20100189744A1

    公开(公告)日:2010-07-29

    申请号:US12732318

    申请日:2010-03-26

    IPC分类号: A61K39/12 A61P31/20

    摘要: The present invention relates to pharmaceutical compositions comprising virus-like particles (VLPs) of HPV, said VLPs adsorbed to an aluminum adjuvant, and an ISCOM-type adjuvant comprising a saponin, cholesterol, and a phospholipid. In preferred embodiments, the aluminum adjuvant comprises amorphous aluminum hydroxyphosphate sulfate. Another aspect of the invention provides multi-dose HPV vaccine formulations comprising HPV VLPs and an antimicrobial preservative selected from the group consisting of: m-cresol, phenol and benzyl alcohol. Also provided are methods of using the disclosed pharmaceutical compositions and formulations to induce an immune response against HPV in a human patient and to prevent HPV infection.

    摘要翻译: 本发明涉及包含HPV病毒样颗粒(VLP),所述VLP吸附于铝佐剂的IS​​MA型佐剂和包含皂角苷,胆固醇和磷脂的ISCOM型佐剂的药物组合物。 在优选的实施方案中,铝佐剂包括无定形的羟基磷酸氢铝硫酸盐。 本发明的另一方面提供了包含HPV VLP和选自间甲酚,苯酚和苄醇的抗微生物防腐剂的多剂量HPV疫苗制剂。 还提供了使用所公开的药物组合物和制剂在人类患者中诱导针对HPV的免疫应答并防止HPV感染的方法。